{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:51:20Z","timestamp":1793238680972,"version":"4.5.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/spc.0000000000000091","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T11:35:45Z","timestamp":1413286545000},"page":"321-327","source":"Crossref","is-referenced-by-count":196,"title":["Role of interleukin-6 in cachexia"],"prefix":"10.1097","volume":"8","author":[{"given":"Aditi A.","family":"Narsale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20211004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways.","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2012.44.2020","article-title":"Possible role for tocilizumab, an antiinterleukin-6 receptor antibody, in treating cancer cachexia.","volume":"31","author":"Ando","year":"2013","journal-title":"J Clin Oncol"},{"key":"R4-3-20211004","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/1078-0432.CCR-11-2133","article-title":"Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies.","volume":"18","author":"Gallagher","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1541-7786.MCR-13-0189","article-title":"The role of inflammatory pathways in cancer-associated cachexia and radiation resistance.","volume":"11","author":"Laine","year":"2013","journal-title":"Mol Cancer Res"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia.","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia.","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R8-3-20211004","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1242\/bio.20136544","article-title":"Characterization of the male ApcMin mouse as a hypogonadism model related to cancer cachexia.","volume":"2","author":"White","year":"2013","journal-title":"Biol Open"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAKSTAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"R10-3-20211004","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s00520-013-1878-4","article-title":"Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer.","volume":"21","author":"Suh","year":"2013","journal-title":"Support Care Cancer"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3892\/ijmm.2014.1825","article-title":"Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis.","volume":"34","author":"Sommer","year":"2014","journal-title":"Int J Mol Med"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2045-3701-4-6","article-title":"Interleukin-6 is required for cell cycle arrest and activation of DNA repair enzymes after partial hepatectomy in mice.","volume":"4","author":"Tachibana","year":"2014","journal-title":"Cell Biosci"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12020-008-9085-7","article-title":"Interleukin-6 stimulates lipolysis in porcine adipocytes.","volume":"33","author":"Yang","year":"2008","journal-title":"Endocrine"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"e57141","DOI":"10.1371\/journal.pone.0057141","article-title":"Early activation of rat skeletal muscle IL-6STAT1STAT3 dependent gene expression in resistance exercise linked to hypertrophy.","volume":"8","author":"Begue","year":"2013","journal-title":"PLoS One"},{"key":"R16-3-20211004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin Immunol"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13539-011-0047-1","article-title":"The effect of exercise on IL-6 induced cachexia in the Apc min mouse.","volume":"3","author":"Puppa","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2014.00058","article-title":"SOCS3, a major regulator of infection and inflammation.","volume":"5","author":"Carow","year":"2014","journal-title":"Front Immunol"},{"key":"R19-3-20211004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/138161211795164202","article-title":"The gp130 receptor cytokine family: regulators of adipocyte development and function.","volume":"17","author":"White","year":"2011","journal-title":"Curr Pharm Des"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.smim.2013.11.002","article-title":"Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities.","volume":"26","author":"Scheller","year":"2014","journal-title":"Semin Immunol"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cyto.2014.05.024","article-title":"Interleukin-6 and its receptors: a highly regulated and dynamic system.","volume":"70","author":"Wolf","year":"2014","journal-title":"Cytokine"},{"key":"R22-3-20211004","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6.","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R23-3-20211004","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1152\/japplphysiol.01270.2013","article-title":"Cachectic skeletal muscle response to a novel bout of low-frequency stimulation.","volume":"116","author":"Puppa","year":"2014","journal-title":"J Appl Physiol"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexia - pathophysiology and management.","volume":"48","author":"Suzuki","year":"2013","journal-title":"J Gastroenterol"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.biocel.2013.05.039","article-title":"Regulation of muscle protein synthesis and the effects of catabolic states.","volume":"45","author":"Gordon","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.","volume":"304","author":"White","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"R29-3-20211004","doi-asserted-by":"crossref","first-page":"e24650","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min) mouse.","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10409238.2013.857291","article-title":"Signaling pathways controlling skeletal muscle mass.","volume":"49","author":"Egerman","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2044-5040-2-14","article-title":"IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the Apc min mouse.","volume":"2","author":"White","year":"2012","journal-title":"Skelet Muscle"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1096\/fj.13-240580","article-title":"Skeletal muscle glycoprotein 130s role in Lewis lung carcinoma-induced cachexia.","volume":"28","author":"Puppa","year":"2014","journal-title":"FASEB J"},{"key":"R33-3-20211004","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3945\/ajcn.113.063859","article-title":"Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients.","volume":"98","author":"Tardif","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm122","article-title":"Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia.","volume":"2","author":"Stephens","year":"2010","journal-title":"Genome Med"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3945\/ajcn.112.045708","article-title":"Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients.","volume":"96","author":"Williams","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"R36-3-20211004","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clnu.2012.05.003","article-title":"Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia.","volume":"31","author":"Winter","year":"2012","journal-title":"Clin Nutr"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"e83618","DOI":"10.1371\/journal.pone.0083618","article-title":"Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle.","volume":"9","author":"Johns","year":"2014","journal-title":"PLoS One"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-14-357","article-title":"Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.","volume":"14","author":"Ruzzo","year":"2014","journal-title":"BMC Cancer"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/emmm.201201869","article-title":"TSC22D4 is a molecular output of hepatic wasting metabolism.","volume":"5","author":"Jones","year":"2013","journal-title":"EMBO Mol Med"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.4049\/jimmunol.1200819","article-title":"Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO.","volume":"189","author":"Sumpter","year":"2012","journal-title":"J Immunol"},{"key":"R41-3-20211004","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.274.5291.1379","article-title":"Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.","volume":"274","author":"Cressman","year":"1996","journal-title":"Science"},{"key":"R42-3-20211004","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","article-title":"Gut barrier dysfunction in the Apc min mouse model of colon cancer cachexia.","volume":"1812","author":"Puppa","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R43-3-20211004","first-page":"2348","article-title":"Bacterial translocation contributes to cachexia from locally advanced gastric cancer.","volume":"59","author":"Mi","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"R45-3-20211004","doi-asserted-by":"crossref","first-page":"e37971","DOI":"10.1371\/journal.pone.0037971","article-title":"Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model.","volume":"7","author":"Bindels","year":"2012","journal-title":"PLoS One"},{"key":"R46-3-20211004","first-page":"8","article-title":"Role of NF-KB in loss of skeletal muscle mass in cancer cachexia and its therapeutic targets.","volume":"1","author":"Srivastava","year":"2013","journal-title":"Am J Cancer Biol"},{"key":"R47-3-20211004","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3945\/jn.113.188367","article-title":"Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin mice.","volume":"144","author":"Velazquez","year":"2014","journal-title":"J Nutr"},{"key":"R49-3-20211004","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer.","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"R50-3-20211004","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","article-title":"Clinical evaluation and optimal management of cancer cachexia.","volume":"88","author":"Tuca","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"R51-3-20211004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000346446","article-title":"Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.","volume":"58","author":"Wen","year":"2012","journal-title":"Chemotherapy"},{"key":"R52-3-20211004","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.biocel.2013.07.016","article-title":"Control of food intake and muscle wasting in cachexia.","volume":"45","author":"Amitani","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"R54-3-20211004","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in nonsmall cell lung cancer.","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"R55-3-20211004","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.jpainsymman.2013.01.009","article-title":"Favorable responses to tocilizumab in two patients with cancer-related cachexia.","volume":"46","author":"Hirata","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"R56-3-20211004","doi-asserted-by":"crossref","first-page":"e102436","DOI":"10.1371\/journal.pone.0102436","article-title":"Tocilizumab, a proposed therapy for the cachexia of interleukin6-expressing lung cancer.","volume":"9","author":"Ando","year":"2014","journal-title":"PLoS One"},{"key":"R57-3-20211004","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1200\/JCO.2012.48.4147","article-title":"Assessment of tocilizumab in the treatment of cancer cachexia.","volume":"31","author":"Berti","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201412000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T09:34:53Z","timestamp":1633512893000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201412000-00003"}},"subtitle":["therapeutic implications"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000091","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}